tiprankstipranks
Advertisement
Advertisement

SharonAI Plans Dual Listing and Australian Capital Raising

Story Highlights
SharonAI Plans Dual Listing and Australian Capital Raising

Claim 55% Off TipRanks

The latest announcement is out from SharonAI Holdings ( (SHAZ) ).

On April 13, 2026, SharonAI Holdings Inc. announced plans to seek a dual listing of its securities on the Australian Securities Exchange in the form of CHESS Depositary Interests, each representing one Class A Ordinary Common share, alongside its existing Nasdaq listing. In conjunction with the proposed ASX admission, the company plans an Australian public offering of CDIs and a concurrent private offering to institutional investors in certain other countries, with existing convertible promissory notes expected to automatically convert into CDIs immediately before ASX listing, a move that could broaden its investor base, deepen access to Australian capital markets and streamline its capital structure, although completion, pricing and proceeds of the offering remain uncertain.

The most recent analyst rating on (SHAZ) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on SharonAI Holdings stock, see the SHAZ Stock Forecast page.

More about SharonAI Holdings

SharonAI Holdings Inc., listed on the Nasdaq Capital Market under the ticker SHAZ, is a high‑performance computing company focused on artificial intelligence and cloud GPU compute infrastructure. The Australian “Neocloud” provider offers a cloud GPU platform that supports AI factories and sovereign AI solutions, targeting the accelerating adoption of advanced, accelerated computing across data‑intensive industries.

Average Trading Volume: 190,031

Technical Sentiment Signal: Sell

Current Market Cap: $496.8M

See more data about SHAZ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1